A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancer
Titel:
A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancer
Auteur:
Falchook, Gerald S. Reeves, James Gandhi, Sunil Spigel, David R. Arrowsmith, Edward George, Daniel J. Karlix, Janet Pouliot, Gayle Hattersley, Maureen M. Gangl, Eric T. James, Gareth D. Thompson, Jeff Russell, Deanna L. Patel, Bhavickumar Kumar, Rakesh Lim, Emerson